Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
6.06
+0.33 (5.76%)
At close: Dec 16, 2025, 4:00 PM EST
5.97
-0.09 (-1.49%)
After-hours: Dec 16, 2025, 7:15 PM EST
Exicure Employees
Exicure had 7 employees as of December 31, 2024. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$1,318,429
Market Cap
38.63M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7 | 1 | 16.67% |
| Dec 31, 2023 | 6 | -7 | -53.85% |
| Dec 31, 2022 | 13 | -34 | -72.34% |
| Dec 31, 2021 | 47 | -16 | -25.40% |
| Dec 31, 2020 | 63 | 34 | 117.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XCUR News
- 7 days ago - Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial - Benzinga
- 8 days ago - Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting - GlobeNewsWire
- 5 weeks ago - Exicure, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting - GlobeNewsWire
- 7 weeks ago - Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 2 months ago - Exicure Highlights Recent Achievements and Near-term Strategic Priorities - GlobeNewsWire
- 4 months ago - Exicure Posts Wider Loss in Fiscal Q2 - The Motley Fool
- 4 months ago - Exicure, Inc. Reports Second Quarter 2025 Financial Results - Business Wire